FernandoTorresMD
Pulmonology • Dallas, TXCritical Care Medicine, Lung Transplantation Medicine, Pleural Disease, Pulmonary Vascular Medicine
Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Torres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2100Fax+1 214-645-3930
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1994 - 1997
Weill Cornell MedicineClass of 1994
Certifications & Licensure
TX State Medical License 1995 - 2026
CO State Medical License 1998 - 2001- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan Start of enrollment: 2009 Jan 01
- Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension Start of enrollment: 2009 Sep 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsSystematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension.Fernando Torres
International Journal of Clinical Practice. 2007-10-01 - 44 citationsOral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inh...Victor F Tapson, Zhi-Cheng Jing, Kai-Feng Xu, Lei Pan, Jeremy Feldman
Chest. 2013-09-01 - 55 citationsOral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibit...Victor F Tapson, Fernando Torres, Fiona Kermeen, Anne M Keogh, Roblee P Allen
Chest. 2012-12-01
Press Mentions
Trumpeter with Transplanted Lungs Lives Out His Dream with MavsOctober 25th, 2017
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
